Dr. Anders Kärnell has supported TFS in study designs, drug development and feasibility mainly within orphan indications.
Dr. Kärnell received his MD degree at Karolinska Institute (Sweden) in 1983. He completed his certified speciality in infectious diseases and clinical bacteriology and his PhD in vaccine development at Karolinska University Hospital at Huddinge.
Dr. Kärnell has also been Chief Physician and Head of the Department of Clinical Bacteriology at Karolinska University Hospital at Huddinge for four years. He gained an Executive MBA from Stockholm School of Economics (2004).
With fourteen years of an industry career in Big Pharma, Biotech and Vaccine companies and senior medical positions in companies in Europe, Dr. Kärnell has considerable experience in Medical Affairs, Clinical Development and Regulatory authority interactions across a wide range of therapeutic areas including orphan drugs. Dr. Kärnell is highly skilled in Clinical Development, Medical Affairs, Product Launch and pricing and reimbursement experience.